CausalSentinel

Protein Dossier — SERPINA4 (Kallistatin)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: bladder problem (not cancer) 0.154 0.0472 0.00108 Inverse variance weighted 2 cis NA
Non-cancer illness code self-reported: bladder problem (not cancer) 0.154 0.0472 0.00108 Inverse variance weighted 2 cis NA
Creatinine (enzymatic) in urine 0.0113 0.00401 0.00472 Inverse variance weighted 2 cis NA
Creatinine (enzymatic) in urine 0.0113 0.00401 0.00472 Inverse variance weighted 2 cis NA
Neo-neuroticism -0.412 0.162 0.011 Inverse variance weighted 2 cis NA
Neo-neuroticism -0.412 0.162 0.011 Inverse variance weighted 2 cis NA
Non-cancer illness code self-reported: hiatus hernia 0.061 0.0259 0.0184 Inverse variance weighted 2 cis NA
Non-cancer illness code self-reported: hiatus hernia 0.061 0.0259 0.0184 Inverse variance weighted 2 cis NA
Fracture resulting from simple fall -0.0248 0.0113 0.0281 Inverse variance weighted 2 cis NA
Fracture resulting from simple fall -0.0248 0.0113 0.0281 Inverse variance weighted 2 cis NA
Neo-agreeableness 0.26 0.126 0.0391 Inverse variance weighted 2 cis NA
Neo-agreeableness 0.26 0.126 0.0391 Inverse variance weighted 2 cis NA
…and 145 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3449_58_2 Kallistatin Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

90 association rows across 40 traits (86 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating SERPINA12 levels 5e-3381 rs17091005 3 GCST90859783 no MR -> candidate analysis
Serpin A12 levels 1e-382 rs4900235 2 GCST90249609 no MR -> candidate analysis
Serum levels of protein SERPINA4 2e-135 rs5511 3 GCST90088394 no MR -> candidate analysis
Kallistatin levels (SERPINA4.3449.58.2) 5e-110 rs10139745 6 GCST90241682 no MR -> candidate analysis
KLK13 protein levels 2e-101 rs5511 2 GCST90469699 no MR -> candidate analysis
SERPINA12 protein levels 2e-96 rs17752932 10 GCST90470581 no MR -> candidate analysis
Kallistatin levels 1e-95 rs5511 9 GCST90161793 no MR -> candidate analysis
Circulating KLK13 levels 8e-95 rs5511 3 GCST90860002 no MR -> candidate analysis
Serum levels of protein SERPINA12 3e-69 rs4900235 1 GCST90089492 no MR -> candidate analysis
Circulating GDF2 levels 2e-66 rs4905214 1 GCST90859810 no MR -> candidate analysis
SERPINA4 protein levels 1e-62 rs10139745 13 GCST90453221 no MR -> candidate analysis
Protein S100-A10 levels 3e-52 rs5511 1 GCST90249400 no MR -> candidate analysis
…and 28 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 230 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
optic atrophy 0.392 common-variant locus no MR -> candidate analysis

Of the 1 rows above, 1 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=1.6e-08, LOEUF=1.33 — LoF-tolerant
GWAS Catalog 170 unique SNPs / 441 rows
ClinVar 119 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance